Abstract:Objective To explore the fluctuation of cytokine mRNA expression level in a novel T-cell-mediated immune hepatic fibrosis model induced by repeatedly injections of Concanavalin A in BALB/c mice. Methods BALB/c mice were divided into different groups. Model group mice were injected weekly up to 20 weeks with Concanavalin A (15mg/kg), via retro-orbital venous plexus under ether anesthesia. Normal control group mice were treated in the same manner weekly with normal saline. Twenty-four hours after Concanavalin A challenge at 1, 5, 12 and 20 week, 8 mice from each time were killed by cervical dislocation, repectively. The livers of different group were excised and fixed in 10% formalin for HE staining and Gomori Ag staining or frozen in optimal cutting temperature (O.C.T.) media in liquid nitrogen for immunohistochemical staining for CD4 +T or CD8 +T cell. After extracting total RNA from liver tissues, IL-2, IL-4, IL-10 and transforming factor β1 messenger RNA were amplified by reverse transcription polymerase chain reaction. PCR products were electrophoresed on agrose containing ethidium bromide and visualized under ultraviolet light. Densitometric RT-PCR data were standardized with β-actin signals. Results The histological change of HE staining and Gomori Ag staining indicated the fibrogenesis in model group mice. Immunohistochemical staining for CD4 + or CD8 + T cell indicated that the infiltrating lymphocytes in liver parenchyma were mainly CD4 +T lymphocytes. IL-2 mRNA expression level only increased after the first injection of Concanavalin A. The expression levels of IL-4, IL-10 and transforming growth factor β1 mRNA significantly increased over the whole experiment period as compared with control group. Conclusions Repeated administration of Concanavalin A can induce T-cell-mediated immune hepatic fibrosis model in BALB/c mice. The expression levels of IL-4, 10 and TGF-β1 increase over the whole experiment period and may play an important role in creating mouse fibrotic model.

The Effect of Suppressive Oligodeoxynucleotide on Pstat4, Pstat6 and T-bet Expression of Concanavalin A-induced Liver Injury in Mice

Effect of Ercao Qinggan Decoction on Acute Liver Injury of Mice with Endotoxemia and the Expression of TLR4 in the Liver

The effect of histone deacetylase inhibitor ACY1215 on the inflammatory response in mice with acute liver failure

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

Effect of TAK1 knockout in CD11c cells on concanavalin A-induced liver injury

Effect of Oxymatrine on Collagen Synthesis and Expression of TGF-β1 in an Immune Hepatic Fibrosis Model

Effect of oridonin on hepatic cytokine levels in mice with LPS/D-Gal-induced acute liver failure

Study on the Mechanism of Oxymatrine on Immune Hepatic Fibrosis Induced by Concanavalin A in BALB/c Mice

Pretreatment with propylene glycol alginate sodium sulfate ameliorated concanavalin A-induced liver injury by regulating the PI3K/Akt pathway in mice

Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6/STAT3-interleukin-17 signaling

Pretreatment with a Low Dose of Concanavalin A Attenuated the Development of Concanavalin A-induced Hepatitis

The Differential Effects of Low Dose and High Dose Concanavalin A on Cytokine Profile and Their Importance in Liver Injury

Sodium Tanshinone IIA Sulfonate Protects Mice From ConA-Induced Hepatitis via Inhibiting NF-κB and IFN-γ/STAT1 Pathways

The protective effects of helix B surface peptide on concanavalin A-induced acute liver injury in mice model

The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.

Establishment and Morphological Study of a Novel T-cell-mediated Immune Hepatic Fibrosis Model in BALB/C Mice

The Prevention and Treatment Effect of Yin-chen-hao Decoction on Concanavalin Ainduced Acute Mice Hepatitis by Inhibiting the Activation of Kupffer cells

The Fluctuation of Cytokine Mrna Expression Level of a Novel T-cell-mediated Immune Hepatic Fibrosis Model in Balb/c Mice

Protective effects of quercetin on ConA-induced acute liver injury in mice

STAT4 Knockout Mice Are More Susceptible to Concanavalin A-induced T-cell Hepatitis.

Effect of Gankang Granules on TNF-αand Protection on Con A Liver Lesion in Mice